Literature DB >> 19727627

[Antisense oligonucleotides for therapy of cystic fibrosis. Inhibition of sodium absorption mediated by ENaC in nasal epithelial cells].

K Sobczak1, N Bangel-Ruland, J Semmler, H Lindemann, R Heermann, W-M Weber.   

Abstract

BACKGROUND: The genetic disease cystic fibrosis (CF) is characterised by reduced chloride secretion mediated by the cystic fibrosis transmembrane conductance regulator (CFTR) and Na(+) hyperabsorption through amiloride-sensitive epithelial sodium channels (ENaC). Mutations in CFTR cause the accumulation of thick mucus and dysfunction of mucociliary clearance in the respiratory tract.
MATERIAL AND METHODS: In this project it was investigated whether Na(+) hyperabsorption is inhibited by the use of antisense oligonucleotides (AON). For functional analyses monolayers of human non-CF and CF nasal epithelial cells were measured in modified Ussing chambers. To analyse the AON effects on the protein level Western blotting analyses were carried out.
RESULTS: AON transfection significantly inhibits Na(+) absorption via ENaC in non-CF and CF cells. Furthermore, Western blot analyses demonstrate a suppression of the ENaC protein in AON transfected human non-CF cells.
CONCLUSION: The inhibition of ENaC associated Na(+) absorption by specific AON could offer a new perspective for the regulation of the Na(+) hyperabsorption in CF patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19727627     DOI: 10.1007/s00106-009-1957-5

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  19 in total

Review 1.  [Gene therapy of cystic fibrosis; review of completed clinical studies].

Authors:  C Coutelle; B Bigger
Journal:  Internist (Berl)       Date:  2001-10       Impact factor: 0.743

2.  Minor role of Cl- secretion in non-cystic fibrosis and cystic fibrosis human nasal epithelium.

Authors:  C Rückes-Nilges; U Weber; H Lindemann; G Münker; W Clauss; W M Weber
Journal:  Cell Physiol Biochem       Date:  1999

3.  [Ion transport in nasal and paranasal sinus mucosa in mucoviscidosis and chronic sinusitis].

Authors:  C Rückes-Nilges; U Weber; C Popp; A Fryen; T Klimek; H Glanz; H Lindemann; G Münker; W Clauss; W M Weber
Journal:  HNO       Date:  1999-03       Impact factor: 1.284

4.  Exploiting the potential of antisense: beyond phosphorothioate oligodeoxynucleotides.

Authors:  C A Stein
Journal:  Chem Biol       Date:  1996-05

5.  Effects of topically delivered benzamil and amiloride on nasal potential difference in cystic fibrosis.

Authors:  T Hofmann; M J Stutts; A Ziersch; C Rückes; W M Weber; M R Knowles; H Lindemann; R C Boucher
Journal:  Am J Respir Crit Care Med       Date:  1998-06       Impact factor: 21.405

6.  Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.

Authors:  Marcus Mall; Barbara R Grubb; Jack R Harkema; Wanda K O'Neal; Richard C Boucher
Journal:  Nat Med       Date:  2004-04-11       Impact factor: 53.440

7.  Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum.

Authors:  R P Tomkiewicz; E M App; J G Zayas; O Ramirez; N Church; R C Boucher; M R Knowles; M King
Journal:  Am Rev Respir Dis       Date:  1993-10

8.  Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo.

Authors:  M R Knowles; J L Carson; A M Collier; J T Gatzy; R C Boucher
Journal:  Am Rev Respir Dis       Date:  1981-10

Review 9.  Physiological basis of cystic fibrosis: a historical perspective.

Authors:  P M Quinton
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

10.  Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

Authors:  J J Smith; S M Travis; E P Greenberg; M J Welsh
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.